Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2020-08-26 Regulatory Filings
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
Book Closure
Regulatory Filings Classification · 100% confidence The document text is extremely short (133 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2020-08-26 English
Outcome of Board Meeting
Regulatory Filings Classification · 90% confidence The document text is extremely short (133 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report title, no regulatory references, or any indication of the document's purpose. Given the lack of content, it cannot be classified as a report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2020-08-24 English
Bonus
Regulatory Filings Classification · 100% confidence The document text is extremely short (133 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2020-08-24 English
Board Meeting — Bonus/Other business matters
Regulatory Filings Classification · 90% confidence The document text is extremely short (69 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report title, no regulatory references, no announcements, or any other information to classify it as a specific filing type. Given the lack of content, the document cannot be classified as a report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2020-08-17 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74 of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30th June 2020. It is a confirmation certificate from the Registrar and Transfer Agent regarding dematerialisation of securities and compliance with SEBI regulations. The document is short (2777 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance documents and certifications that do not fit other specific categories.
2020-07-25 English
Reply to Clarification Sought
Board/Management Information Classification · 95% confidence The document is a letter addressed to NSE Limited Emerge Platform, dated 8th July 2020, providing the profile of Mr. Parag Manubhai Shah. It includes biographical details and experience relevant to his appointment. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The content is focused on management personnel information, specifically the profile of a director or senior management individual. This fits the category of Board/Management Information (MANG), which covers announcements of changes or appointments in the company's board or senior management.
2020-07-08 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.